Augmenting advance care planning in poor prognosis cancer with a video decision aid
Angelo E. Volandes(Massachusetts General Hospital), Ariela Noy(Memorial Sloan Kettering Cancer Center), Michael J. Morris(Dana-Farber Cancer Institute), Elizabeth Walker-Corkery, Susan F. Slovin(Cornell University), Yuchiao Chang(Harvard University), Tomer T. Levin, Mary Louise Keohan(Roche (Switzerland)), John F. Gerecitano(Memorial Sloan Kettering Cancer Center), Maura N. Dickler(Memorial Sloan Kettering Cancer Center), Eileen M. O’Reilly(Memorial Sloan Kettering Cancer Center), Andrew S. Epstein(Memorial Sloan Kettering Cancer Center), Anastazia Naka‐Blackstone(Memorial Sloan Kettering Cancer Center), Richard D. Carvajal(Northwell Health), Maria Theodoulou(Memorial Sloan Kettering Cancer Center)
Cited by 79
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Prevalence of Diagnosed Atrial Fibrillation in Adults
|JAMA|2001|6.2k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
|Journal of Clinical Oncology|2014|2.2k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k